GB202109894D0 - Novel treatments - Google Patents
Novel treatmentsInfo
- Publication number
- GB202109894D0 GB202109894D0 GBGB2109894.2A GB202109894A GB202109894D0 GB 202109894 D0 GB202109894 D0 GB 202109894D0 GB 202109894 A GB202109894 A GB 202109894A GB 202109894 D0 GB202109894 D0 GB 202109894D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- novel treatments
- treatments
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2109894.2A GB202109894D0 (en) | 2021-07-08 | 2021-07-08 | Novel treatments |
EP22747660.3A EP4366721A1 (en) | 2021-07-08 | 2022-07-07 | Melflufen for use in the treatment of multiple myeloma |
PCT/EP2022/068974 WO2023281007A1 (en) | 2021-07-08 | 2022-07-07 | Melflufen for use in the treatment of multiple myeloma |
TW111125748A TW202317084A (en) | 2021-07-08 | 2022-07-08 | Novel treatments |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2109894.2A GB202109894D0 (en) | 2021-07-08 | 2021-07-08 | Novel treatments |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202109894D0 true GB202109894D0 (en) | 2021-08-25 |
Family
ID=77353917
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2109894.2A Ceased GB202109894D0 (en) | 2021-07-08 | 2021-07-08 | Novel treatments |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB202109894D0 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001096367A1 (en) | 2000-06-13 | 2001-12-20 | Oncopeptides Ab | Melphalan derivatives and their use as cancer chemotherapeutic drugs |
WO2012146625A1 (en) | 2011-04-28 | 2012-11-01 | Oncopeptides Ab | Lyophilized preparation of cytotoxic dipeptides |
WO2014065751A1 (en) | 2012-10-26 | 2014-05-01 | Oncopeptides Ab | Lyophilized preparations of melphalan flufenamide |
WO2014065741A1 (en) | 2012-10-22 | 2014-05-01 | Parker Hannifin Manufacturing Sweden Ab | Joystick |
WO2020079165A1 (en) | 2018-10-18 | 2020-04-23 | Oncopeptides Ab | Compounds containing deuterium |
WO2020212594A1 (en) | 2019-04-17 | 2020-10-22 | Oncopeptides Ab | Novel formulations comprising melflufen |
-
2021
- 2021-07-08 GB GBGB2109894.2A patent/GB202109894D0/en not_active Ceased
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001096367A1 (en) | 2000-06-13 | 2001-12-20 | Oncopeptides Ab | Melphalan derivatives and their use as cancer chemotherapeutic drugs |
WO2012146625A1 (en) | 2011-04-28 | 2012-11-01 | Oncopeptides Ab | Lyophilized preparation of cytotoxic dipeptides |
WO2014065741A1 (en) | 2012-10-22 | 2014-05-01 | Parker Hannifin Manufacturing Sweden Ab | Joystick |
WO2014065751A1 (en) | 2012-10-26 | 2014-05-01 | Oncopeptides Ab | Lyophilized preparations of melphalan flufenamide |
WO2020079165A1 (en) | 2018-10-18 | 2020-04-23 | Oncopeptides Ab | Compounds containing deuterium |
WO2020212594A1 (en) | 2019-04-17 | 2020-10-22 | Oncopeptides Ab | Novel formulations comprising melflufen |
Non-Patent Citations (11)
Title |
---|
"Surveillance, Epidemiology, and End Results Program Cancer statistics Stat Fact Sheets: Myeloma", NATIONAL CANCER INSTITUTE, Retrieved from the Internet <URL:http://www.seer.cancer.gov/statfacts/html/mulmy.html> |
BYRN ET AL., PHARM RES, vol. 12, no. 7, 1995, pages 945 - 954 |
ELNAIRHOLSTEIN, ONCOLOGY, vol. 35, pages 170 - 182 |
MOREAU, P. ET AL., J CLIN ONCOL, vol. 29, 2011, pages 1898 - 1906 |
PALUMBO, A ET AL., J CLIN ONCOL, vol. 32, 2014, pages 587 - 600 |
PIECHOTTA V ET AL.: "Multiple drug combinations of bortezomib, lenalidomide, and thalidomide for first-line treatment in adults with transplant-ineligible multiple myeloma: a network meta-analysis", COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019 |
RICHARDSON, P. G ET AL., JOURNAL OF CLINICAL ONCOLOGY, vol. 39, no. 7, 2021, pages 757 - 767 |
ROSINOL, L. ET AL., EXPERT REV HEMATOL, vol. 7, 2014, pages 43 - 53 |
STILLER CA ET AL., CANCER EPIDEMIOL, vol. 56, 2018, pages 146 - 153 |
STILLER CA ET AL., CANCER EPIDEMIOL., vol. 56, 2018, pages 146 - 153 |
WANG, Y. J.HANSON, M. A., JOURNAL OF PARENTERAL SCIENCE AND TECHNOLOGY, TECHNICAL REPORT, no. 10, 1988 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB202006390D0 (en) | Novel treatments | |
GB202016058D0 (en) | Therapeautic treatment | |
GB202003722D0 (en) | Treatment | |
GB202002711D0 (en) | Treatment | |
GB202116339D0 (en) | Novel treatments | |
GB202112981D0 (en) | Novel treatments | |
GB202112980D0 (en) | Novel treatments | |
GB202112976D0 (en) | Novel treatments | |
GB202112977D0 (en) | Novel treatments | |
GB202112978D0 (en) | Novel treatments | |
GB202112979D0 (en) | Novel treatments | |
GB202109894D0 (en) | Novel treatments | |
GB202109895D0 (en) | Novel treatments | |
GB202109896D0 (en) | Novel treatments | |
GB202103400D0 (en) | Novel treatments | |
GB202101296D0 (en) | Novel treatments | |
GB202101292D0 (en) | Novel treatments | |
GB202101291D0 (en) | Novel treatments | |
GB202017858D0 (en) | Novel treatments | |
GB202010259D0 (en) | Novel Treatments | |
GB202317035D0 (en) | Novel treatments | |
GB202316907D0 (en) | Novel treatments | |
GB202205069D0 (en) | Novel treatments | |
GB202205070D0 (en) | Novel treatments | |
GB202009086D0 (en) | New treatments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |